Author:
Liu Bing,Huang Jian-wen,Li Yong,Hu Bao-shan,He Xu,Zhao Wei,Zheng You-bing,Lu Li-gong
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference18 articles.
1. Baj G, Arnulfo A, Deaglio S, Mallone R, Vigone A, De Cesaris MG, Surico N, Malavasi F, Ferrero E (2002) Arsenic trioxide and breast cancer: analysis of the apoptotic, differentiative and immunomodulatory effects. Breast Cancer Res Treat 1:71–73
2. Cabrera R, Nelson DR (2010) Review article: the management of hepatocellular carcinoma. Aliment Pharmacol Ther 31(4):461–476
3. Chen GQ, Shi XG, Tang W et al (1997) Use of arsenic trioxide (arsenic trioxide) in the treatment of acute promyelocytic leukemia (APL): I. Arsenic Trioxide exerts dose-dependent dual effects on APL cells. Blood 89(9):3345–3353
4. Cheng AL, Kang YK, Chen Z et al (2009) Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 10:25–34
5. Eisenhauer EA et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228–247
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献